跳至主要内容
临床试验/PACTR202011894723114
PACTR202011894723114Other4 期

Pharmacodynamic specificities of rocuronium in sickle cell patients

ARES ULB0 个研究点目标入组 45 人开始时间: 2020年11月13日最近更新:
适应症

试验速览

阶段
4 期
状态
Other
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • Sickle cell patients requiring elective laparoscopic surgery (defined as patients who did not require emergency surgery within 12 hours following admission to the hospital), as well as non-sickle cell patients matched to the same types of surgical procedures for the control group were included. After informed consent from patients, we included twenty two 22” patients in the sickle cell patients and twenty three 23 patients in the control group. There were three 03” main indications for surgery: cholecystectomy, appendectomy, and splenectomy.

排除标准

  • We did not include patients age less than 18 and over 55 years, pregnancy, emergency surgery or surgery within the 12 hours following admission to the ward, predicted difficult ventilation or intubation, body mass index (BMI) over 30, known muscular disease, liver disease and in control group chronic renal disease and ASA 3 patients.

研究者

发起方
ARES ULB

相似试验